Literature DB >> 10619504

Mesothelioma clinical presentation.

R Bueno1.   

Abstract

OBJECTIVES: Clinical teaching of treatment for mesothelioma
DESIGN: Case presentation
SETTING: Postgraduate course. PATIENT: A 52-year-old man with chest pain
INTERVENTIONS: Multimodality therapy consisted of surgery, intrapleural chemotherapy, chemotherapy, and radiation therapy.
RESULTS: Patient is alive and well 2 years after surgery.
CONCLUSIONS: Aggressive trimodality therapy for mesothelioma is presented as a successful treatment option.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619504     DOI: 10.1378/chest.116.suppl_3.444s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.

Authors:  Tong Li; Hui Li; Yucheng Wang; Chansonette Harvard; Jia-Li Tan; Alfred Au; Zhidong Xu; David M Jablons; Liang You
Journal:  J Pathol       Date:  2011-01-05       Impact factor: 7.996

2.  Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma.

Authors:  Junichi Okamoto; Iwao Mikami; Yuichi Tominaga; Kristopher M Kuchenbecker; Yu-Ching Lin; Dawn T Bravo; Genevieve Clement; Adam Yagui-Beltran; M Roshni Ray; Kiyoshi Koizumi; Biao He; David M Jablons
Journal:  J Thorac Oncol       Date:  2008-10       Impact factor: 15.609

3.  Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients.

Authors:  Masashi Kobayashi; Cheng-Long Huang; Makoto Sonobe; Ryutaro Kikuchi; Masashi Ishikawa; Jiro Kitamura; Ryo Miyahara; Toshi Menju; Shotaro Iwakiri; Kazumi Itoi; Ryoji Yasumizu; Hiroshi Date
Journal:  Exp Ther Med       Date:  2012-03-12       Impact factor: 2.447

4.  Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?

Authors:  Constantin Lapa; Stefan Kircher; Andreas Schirbel; Andreas Rosenwald; Saskia Kropf; Theo Pelzer; Thorsten Walles; Andreas K Buck; Wolfgang A Weber; Hans-Juergen Wester; Ken Herrmann; Katharina Lückerath
Journal:  Oncotarget       Date:  2017-05-27

5.  Cul4A is an oncogene in malignant pleural mesothelioma.

Authors:  Ming-Szu Hung; Jian-Hua Mao; Zhidong Xu; Cheng-Ta Yang; Jau-Song Yu; Chansonette Harvard; Yu-Ching Lin; Dawn Therese Bravo; David M Jablons; Liang You
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.